SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Wollmann B. M.)
 

Search: WFRF:(Wollmann B. M.) > (2007-2009) > Major determinants ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS

Ranke, M. B. (author)
Lindberg, A. (author)
Ferrandez Longas, A. (author)
show more...
Darendeliler, F. (author)
Albertsson-Wikland, Kerstin, 1947 (author)
Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper,Institute of Clinical Sciences
Dunger, D. (author)
Cutfield, W. S. (author)
Tauber, M. (author)
Wilton, P. (author)
Wollmann, H. A. (author)
Reiter, E. O. (author)
show less...
 (creator_code:org_t)
Springer Science and Business Media LLC, 2007
2007
English.
In: Pediatr Res. - : Springer Science and Business Media LLC. - 0031-3998. ; 61:1, s. 105-10
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Little is known about factors determining height outcome during GH treatment in Turner syndrome (TS). We investigated 987 TS children within the Kabi International Growth Study (KIGS) who had reached near adult height (NAH) after >4 y GH treatment (including >1 y before puberty). Through multiple regression analysis we developed a model for NAH and total gain. Our results were as follows (median): 1) At start, age 9.7 yrs, height (HT) 118.0 cm (0.0 TS SDS), projected adult height 146.1 cm, GH dose 0.27 mg/kg wk; 2) NAH HT 151.0 cm (1.5 TS SDS); 3) Prepubertal gain 21.2 cm (1.6 TS SDS); 4) Pubertal gain 9.4 cm (0.0 TS SDS). NAH correlated (r = 0.67) with (ranked) HT at GH start (+), 1 year responsiveness to GH (+), MPH (+), age at puberty onset (+), age at GH start (-), and dose (+). The same factors explained (R = 0.90) the total HT gain. However, HT at GH start correlated negatively. Karyotype had no influence on outcome. Evidently, height at GH start (the taller, the better), age at GH start (the younger, the better), the responsiveness to GH (the higher, the better) and age at puberty (the later, the better) determine NAH.

Keyword

Adolescent
Body Height/*drug effects
Child
Female
Human Growth Hormone/*therapeutic use
Humans
Turner Syndrome/*drug therapy

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view